BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16946032)

  • 1. Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain.
    Faraco G; Pancani T; Formentini L; Mascagni P; Fossati G; Leoni F; Moroni F; Chiarugi A
    Mol Pharmacol; 2006 Dec; 70(6):1876-84. PubMed ID: 16946032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor: effects on gene expression and growth of glioma cells in vitro and in vivo.
    Yin D; Ong JM; Hu J; Desmond JC; Kawamata N; Konda BM; Black KL; Koeffler HP
    Clin Cancer Res; 2007 Feb; 13(3):1045-52. PubMed ID: 17289901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug insight: Histone deacetylase inhibitors--development of the new targeted anticancer agent suberoylanilide hydroxamic acid.
    Kelly WK; Marks PA
    Nat Clin Pract Oncol; 2005 Mar; 2(3):150-7. PubMed ID: 16264908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone deacetylase as therapeutic target in a rodent model of hemorrhagic shock: effect of different resuscitation strategies on lung and liver.
    Lin T; Chen H; Koustova E; Sailhamer EA; Li Y; Shults C; Liu B; Rhee P; Kirkpatrick J; Alam HB
    Surgery; 2007 Jun; 141(6):784-94. PubMed ID: 17560255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zn(II)-dependent histone deacetylase inhibitors: suberoylanilide hydroxamic acid and trichostatin A.
    Codd R; Braich N; Liu J; Soe CZ; Pakchung AA
    Int J Biochem Cell Biol; 2009 Apr; 41(4):736-9. PubMed ID: 18725319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone deacetylase inhibitors induce apoptosis, histone hyperacetylation and up-regulation of gene transcription in Schistosoma mansoni.
    Dubois F; Caby S; Oger F; Cosseau C; Capron M; Grunau C; Dissous C; Pierce RJ
    Mol Biochem Parasitol; 2009 Nov; 168(1):7-15. PubMed ID: 19538992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.
    Fedier A; Dedes KJ; Imesch P; Von Bueren AO; Fink D
    Int J Oncol; 2007 Sep; 31(3):633-41. PubMed ID: 17671692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 reverses the histone deacetylase inhibitor-induced increase in glial glutamate transporter transcription without affecting histone acetylation levels.
    Allritz C; Bette S; Figiel M; Engele J
    Neurochem Int; 2009; 55(1-3):22-7. PubMed ID: 19428803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of apoptosis in renal tubular cells by histone deacetylase inhibitors, a family of anticancer agents.
    Dong G; Wang L; Wang CY; Yang T; Kumar MV; Dong Z
    J Pharmacol Exp Ther; 2008 Jun; 325(3):978-84. PubMed ID: 18310471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid reduces brain damage induced by transient focal cerebral ischemia in rats: potential roles of histone deacetylase inhibition and heat shock protein induction.
    Ren M; Leng Y; Jeong M; Leeds PR; Chuang DM
    J Neurochem; 2004 Jun; 89(6):1358-67. PubMed ID: 15189338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of histone deacetylation by trichostatin A intensifies the transcriptions of neuronal c-fos and c-jun genes after kainate stimulation.
    Sng JC; Taniura H; Yoneda Y
    Neurosci Lett; 2005 Oct; 386(3):150-5. PubMed ID: 16002216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiol-based SAHA analogues as potent histone deacetylase inhibitors.
    Suzuki T; Kouketsu A; Matsuura A; Kohara A; Ninomiya S; Kohda K; Miyata N
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3313-7. PubMed ID: 15149697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbonyl- and sulfur-containing analogs of suberoylanilide hydroxamic acid: Potent inhibition of histone deacetylases.
    Gu W; Nusinzon I; Smith RD; Horvath CM; Silverman RB
    Bioorg Med Chem; 2006 May; 14(10):3320-9. PubMed ID: 16434199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and ex vivo evaluation of second-generation histone deacetylase inhibitors for the treatment of spinal muscular atrophy.
    Hahnen E; Eyüpoglu IY; Brichta L; Haastert K; Tränkle C; Siebzehnrübl FA; Riessland M; Hölker I; Claus P; Romstöck J; Buslei R; Wirth B; Blümcke I
    J Neurochem; 2006 Jul; 98(1):193-202. PubMed ID: 16805808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway.
    Hrzenjak A; Kremser ML; Strohmeier B; Moinfar F; Zatloukal K; Denk H
    J Pathol; 2008 Dec; 216(4):495-504. PubMed ID: 18850582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemosensitization of oral squamous cell carcinoma cells to cisplatin by histone deacetylase inhibitor, suberoylanilide hydroxamic acid.
    Rikiishi H; Shinohara F; Sato T; Sato Y; Suzuki M; Echigo S
    Int J Oncol; 2007 May; 30(5):1181-8. PubMed ID: 17390020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of airway inflammation.
    Adcock IM; Tsaprouni L; Bhavsar P; Ito K
    Curr Opin Immunol; 2007 Dec; 19(6):694-700. PubMed ID: 17720468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in histone acetylation during mouse oocyte meiosis.
    Kim JM; Liu H; Tazaki M; Nagata M; Aoki F
    J Cell Biol; 2003 Jul; 162(1):37-46. PubMed ID: 12835313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of histone deacetylation inhibition on neuronal differentiation of embryonic mouse neural stem cells.
    Balasubramaniyan V; Boddeke E; Bakels R; Küst B; Kooistra S; Veneman A; Copray S
    Neuroscience; 2006 Dec; 143(4):939-51. PubMed ID: 17084985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury.
    Leinhase I; Schmidt OI; Thurman JM; Hossini AM; Rozanski M; Taha ME; Scheffler A; John T; Smith WR; Holers VM; Stahel PF
    Exp Neurol; 2006 Jun; 199(2):454-64. PubMed ID: 16545803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.